6 completed. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow ERYtech Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase GRASPA - Acute Lymphoblastic Leukemia | Phase 2 | Completed | Birgitte Klug Albertsen | 55 | 2017-08-23 | 2024-03-15 |
| Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma ERY001, Gemcitabine, 5-fluoro-uracil/oxaliplatin/leucovorin (folfox) - Pancreatic Adenocarcinoma Metastatic | Phase 2 | Completed | ERYtech Pharma | 141 | 2014-07-01 | 2018-07-27 |
| GRASPA Treatment for Patients With Acute Myeloblastic Leukemia GRASPA - Acute Myeloid Leukemia | Phase 2 | Completed | ERYtech Pharma | 123 | 2013-02-01 | 2022-02-21 |
| GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia GRASPA, L-asparaginase - Acute Lymphoblastic Leukemia, in Relapse | Phase 2 / Phase 3 | Completed | ERYtech Pharma | 85 | 2009-12-01 | 2022-02-02 |
| Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia GRASPA - Acute Lymphoblastic Leukemia | Phase 2 | Completed | ERYtech Pharma | 30 | 2009-04-01 | 2021-10-15 |
| Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia GRASPA, native L asparaginase - Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Completed | ERYtech Pharma | 25 | 2006-01-01 | 2012-01-11 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Recurrence (2) · Adenocarcinoma (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Neoplasms (1)
eryaspase (2) · Asparaginase (1) · Erythrocyte Count (1) · Folfox protocol (1) · Gemcitabine (1)
France (4) · Belgium (1) · Denmark (1) · Estonia (1) · Finland (1) · Lithuania (1) · Norway (1) · Sweden (1)
Brigitte Klug Albertsen, MD, PhD (1) · Mathilde Hunault-Berger, Professor (1) · Pascal Hammel, Pr MD (1) · X Thomas, Doctor (1) · Yves Bertand, MD (1) · Yves Bertrand, MD PhD (1)
PMID 26094614, PMID 31760314, PMID 32605910
2016 (1)